221 related articles for article (PubMed ID: 2825110)
1. Immunoglobulin subclass antibodies to varicella-zoster virus.
Asano Y; Hiroishi Y; Itakura N; Hirose S; Kajita Y; Nagai T; Yazaki T; Takahashi M
Pediatrics; 1987 Dec; 80(6):933-6. PubMed ID: 2825110
[TBL] [Abstract][Full Text] [Related]
2. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies.
Vartdal F; Vandvik B
Clin Exp Immunol; 1983 Dec; 54(3):641-7. PubMed ID: 6317243
[TBL] [Abstract][Full Text] [Related]
4. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
5. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
Austgulen R
Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
[TBL] [Abstract][Full Text] [Related]
6. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
[TBL] [Abstract][Full Text] [Related]
7. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
8. Use of statistical models for evaluating antibody response as a correlate of protection against varicella.
Chan IS; Li S; Matthews H; Chan C; Vessey R; Sadoff J; Heyse J
Stat Med; 2002 Nov; 21(22):3411-30. PubMed ID: 12407681
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of varicella-zoster virus (VZV)-specific antibodies in the early phase of varicella in immunocompromized children.
Nyerges G; Mészner Z; Simon M
Acta Microbiol Hung; 1983; 30(3-4):211-5. PubMed ID: 6326459
[TBL] [Abstract][Full Text] [Related]
10. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
[TBL] [Abstract][Full Text] [Related]
11. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
[TBL] [Abstract][Full Text] [Related]
12. Isolation of varicella-zoster virus from vesicles in children with varicella.
Ozaki T; Kajita Y; Namazue J; Yamanishi K
J Med Virol; 1996 Apr; 48(4):326-8. PubMed ID: 8699164
[TBL] [Abstract][Full Text] [Related]
13. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
Berger R; Luescher D; Just M
Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
[TBL] [Abstract][Full Text] [Related]
14. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
[TBL] [Abstract][Full Text] [Related]
15. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
Brunell PA; Geiser CF; Novelli V; Lipton S; Narkewicz S
Pediatrics; 1987 Jun; 79(6):922-7. PubMed ID: 3035478
[TBL] [Abstract][Full Text] [Related]
16. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Sauerbrei A; Wutzler P
Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
[TBL] [Abstract][Full Text] [Related]
17. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated varicella vaccine use in immunocompromised children and adults.
Gershon AA; Steinberg SP; Gelb L
Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
[TBL] [Abstract][Full Text] [Related]
19. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
[TBL] [Abstract][Full Text] [Related]
20. A live varicella vaccine in a pediatric community.
Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
